The latest in MOFCOM's remedy supervision

November 26, 2015 | BY

Katherine Jo

O'Melveny & Myers

Nate Bush and Lining Shan [email protected] and [email protected]

 

Many antitrust regulators worldwide prefer to address potential anti-competitive effects from mergers among competitors with one-time “structural” fixes (such as divestitures of subsidiaries, facilities or IP), wary that “behavioral” remedies that restrict merger parties' future commercial conduct may entail ongoing administrative costs and unintended harm to consumers.

This premium content is reserved for
China Law & Practice Subscribers.

  • A database of over 3,000 essential documents including key PRC legislation translated into English
  • A choice of newsletters to alert you to changes affecting your business including sector specific updates
  • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]